Hybrid cardiovascular imaging. A clinical consensus statement of the european association of nuclear medicine (EANM) and the european association of cardiovascular imaging (EACVI) of the ESC.
Cardiovascular imaging
Hybrid imaging
PET/CT
PET/MR
Journal
European journal of nuclear medicine and molecular imaging
ISSN: 1619-7089
Titre abrégé: Eur J Nucl Med Mol Imaging
Pays: Germany
ID NLM: 101140988
Informations de publication
Date de publication:
22 Oct 2024
22 Oct 2024
Historique:
received:
08
09
2024
accepted:
06
10
2024
medline:
22
10
2024
pubmed:
22
10
2024
entrez:
22
10
2024
Statut:
aheadofprint
Résumé
Hybrid imaging consists of a combination of two or more imaging modalities, which equally contribute to image information. To date, hybrid cardiovascular imaging can be performed by either merging images acquired on different scanners, or with truly hybrid PET/CT and PET/MR scanners. The European Association of Nuclear Medicine (EANM), and the European Association of Cardiovascular Imaging (EACVI) of the European Society of Cardiology (ESC) aim to review clinical situations that may benefit from the use of hybrid cardiac imaging and provide advice on acquisition protocols providing the most relevant information to reach diagnosis in various clinical situations.
Identifiants
pubmed: 39436435
doi: 10.1007/s00259-024-06946-w
pii: 10.1007/s00259-024-06946-w
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s).
Références
Gaemperli O, Saraste A, Knuuti J. Cardiac hybrid imaging. Eur Heart J Cardiovasc Imaging. 2012;13(1):51–60. https://doi.org/10.1093/ejechocard/jer240 .
doi: 10.1093/ejechocard/jer240
pubmed: 22094239
Guaricci AI, Neglia D, Acampa W, Andreini D, Baggiano A, Bianco F, et al. Computed tomography and nuclear medicine for the assessment of coronary inflammation: clinical applications and perspectives. J Cardiovasc Med (Hagerstown). 2023;24(Suppl 1):e67-76. https://doi.org/10.2459/JCM.0000000000001433 .
doi: 10.2459/JCM.0000000000001433
pubmed: 37052223
Whittington B, Dweck MR, van Beek EJR, Newby D, Williams MC. PET-MRI of coronary artery disease. J Magn Reson Imaging. 2023;57(5):1301–11. https://doi.org/10.1002/jmri.28554 .
doi: 10.1002/jmri.28554
pubmed: 36524452
Kwiecinski J, Wolny R, Chwala A, Slomka P. Advances in the assessment of coronary artery disease activity with PET/CT and CTA. Tomography. 2023;9(1):328–41. https://doi.org/10.3390/tomography9010026 .
doi: 10.3390/tomography9010026
pubmed: 36828378
pmcid: 9962109
Kirienko M, Erba PA, Chiti A, Sollini M. Hybrid PET/MRI in infection and inflammation: an update about the latest available literature evidence. Semin Nucl Med. 2023;53(1):107–24. https://doi.org/10.1053/j.semnuclmed.2022.10.005 .
doi: 10.1053/j.semnuclmed.2022.10.005
pubmed: 36369091
Kaufmann PA. Cardiac PET/MR: big footprint-small step. J Nucl Cardiol. 2015;22(2):225–6. https://doi.org/10.1007/s12350-015-0089-4 .
doi: 10.1007/s12350-015-0089-4
pubmed: 25711286
Santana CA, Garcia EV, Faber TL, Sirineni GK, Esteves FP, Sanyal R, et al. Diagnostic performance of fusion of myocardial perfusion imaging (MPI) and computed tomography coronary angiography. J Nucl Cardiol. 2009;16(2):201–11. https://doi.org/10.1007/s12350-008-9019-z .
doi: 10.1007/s12350-008-9019-z
pubmed: 19156478
pmcid: 3086676
Slomka PJ, Cheng VY, Dey D, Woo J, Ramesh A, Van Kriekinge S, et al. Quantitative analysis of myocardial perfusion SPECT anatomically guided by coregistered 64-slice coronary CT angiography. J Nucl Med. 2009;50(10):1621–30. https://doi.org/10.2967/jnumed.109.063982 .
doi: 10.2967/jnumed.109.063982
pubmed: 19759104
Pazhenkottil AP, Nkoulou RN, Ghadri JR, Herzog BA, Buechel RR, Küest SM, et al. Prognostic value of cardiac hybrid imaging integrating single-photon emission computed tomography with coronary computed tomography angiography. Eur Heart J. 2011;32(12):1465–71. https://doi.org/10.1093/eurheartj/ehr047 .
doi: 10.1093/eurheartj/ehr047
pubmed: 21320906
Kajander S, Joutsiniemi E, Saraste M, Pietilä M, Ukkonen H, Saraste A, et al. Cardiac positron emission tomography/computed tomography imaging accurately detects anatomically and functionally significant coronary artery disease. Circulation. 2010;122(6):603–13. https://doi.org/10.1161/CIRCULATIONAHA.109.915009 .
doi: 10.1161/CIRCULATIONAHA.109.915009
pubmed: 20660808
Maaniitty T, Stenström I, Bax JJ, Uusitalo V, Ukkonen H, Kajander S, et al. Prognostic value of coronary CT angiography with selective PET perfusion imaging in coronary artery disease. JACC Cardiovasc Imaging. 2017;10(11):1361–70. https://doi.org/10.1016/j.jcmg.2016.10.025 .
doi: 10.1016/j.jcmg.2016.10.025
pubmed: 28528146
Gitsioudis G, Marwan M, Schneider S, Schmermund A, Korosoglou G, Hausleiter J, et al. A systematic report on non-coronary cardiac CTA in 1097 patients from the German cardiac CT registry. Eur J Radiol. 2020;130:109136. https://doi.org/10.1016/j.ejrad.2020.109136 .
doi: 10.1016/j.ejrad.2020.109136
pubmed: 32634756
Abbara S, Blanke P, Maroules CD, Cheezum M, Choi AD, Han BK, et al. SCCT guidelines for the performance and acquisition of coronary computed tomographic angiography: a report of the society of cardiovascular computed tomography guidelines committee: endorsed by the North American society for cardiovascular imaging (NASCI). J Cardiovasc Comput Tomogr. 2016;10(6):435–49. https://doi.org/10.1016/j.jcct.2016.10.002 .
doi: 10.1016/j.jcct.2016.10.002
pubmed: 27780758
Verberne HJ, Acampa W, Anagnostopoulos C, Ballinger J, Bengel F, De Bondt P, et al. EANM procedural guidelines for radionuclide myocardial perfusion imaging with SPECT and SPECT/CT: 2015 revision. Eur J Nucl Med Mol Imaging. 2015;42(12):1929–40. https://doi.org/10.1007/s00259-015-3139-x .
doi: 10.1007/s00259-015-3139-x
pubmed: 26290421
pmcid: 4589547
Pontone G, Rossi A, Guglielmo M, Dweck MR, Gaemperli O, Nieman K, et al. Clinical applications of cardiac computed tomography: a consensus paper of the European Association of Cardiovascular Imaging-part I. Eur Heart J Cardiovasc Imaging. 2022;23(3):299–314. https://doi.org/10.1093/ehjci/jeab293 .
doi: 10.1093/ehjci/jeab293
pubmed: 35076061
pmcid: 8863074
Pontone G, Rossi A, Guglielmo M, Dweck MR, Gaemperli O, Nieman K, et al. Clinical applications of cardiac computed tomography: a consensus paper of the European association of cardiovascular imaging-part II. Eur Heart J Cardiovasc Imaging. 2022;23(4):e136–61. https://doi.org/10.1093/ehjci/jeab292 .
doi: 10.1093/ehjci/jeab292
pubmed: 35175348
pmcid: 8944330
Hausleiter J, Meyer T, Hermann F, Hadamitzky M, Krebs M, Gerber TC, et al. Estimated radiation dose associated with cardiac CT angiography. JAMA. 2009;301(5):500–7. https://doi.org/10.1001/jama.2009.54 .
doi: 10.1001/jama.2009.54
pubmed: 19190314
Marwan M, Achenbach S, Korosoglou G, Schmermund A, Schneider S, Bruder O, et al. German cardiac CT registry: indications, procedural data and clinical consequences in 7061 patients undergoing cardiac computed tomography. Int J Cardiovasc Imaging. 2018;34(5):807–19. https://doi.org/10.1007/s10554-017-1282-0 .
doi: 10.1007/s10554-017-1282-0
pubmed: 29197025
Gimelli A, Achenbach S, Buechel RR, Edvardsen T, Francone M, Gaemperli O, et al. Strategies for radiation dose reduction in nuclear cardiology and cardiac computed tomography imaging: a report from the European association of cardiovascular imaging (EACVI), the cardiovascular committee of European association of nuclear medicine (EANM), and the European society of cardiovascular radiology (ESCR). Eur Heart J. 2018;39(4):286–96. https://doi.org/10.1093/eurheartj/ehx582 .
doi: 10.1093/eurheartj/ehx582
pubmed: 29059384
Voros S, Qian Z. Agatston score tried and true: by contrast, can we quantify calcium on CTA. J Cardiovasc Comput Tomogr. 2012;6(1):45–7. https://doi.org/10.1016/j.jcct.2011.12.002 .
doi: 10.1016/j.jcct.2011.12.002
pubmed: 22264631
Kędzierski B, Macek P, Dziadkowiec-Macek B, Truszkiewicz K, Poręba R, Gać P. Radiation doses in cardiovascular computed tomography. Life (Basel). 2023;13(4):990. https://doi.org/10.3390/life13040990 .
doi: 10.3390/life13040990
pubmed: 37109519
Jang J, Jung SE, Jeong WK, Lim YS, Choi JI, Park MY, et al. Radiation doses of various CT Protocols: a multicenter longitudinal observation study. J Korean Med Sci. 2016;31 Suppl 1(Suppl 1):S24–31. https://doi.org/10.3346/jkms.2016.31.S1.S24 .
Martinez-Möller A, Souvatzoglou M, Navab N, Schwaiger M, Nekolla SG. Artifacts from misaligned CT in cardiac perfusion PET/CT studies: frequency, effects, and potential solutions. J Nucl Med. 2007;48(2):188–93.
pubmed: 17268013
Lautamäki R, Brown TL, Merrill J, Bengel FM. CT-based attenuation correction in (82)Rb-myocardial perfusion PET-CT: incidence of misalignment and effect on regional tracer distribution. Eur J Nucl Med Mol Imaging. 2008;35(2):305–10. https://doi.org/10.1007/s00259-007-0607-y .
doi: 10.1007/s00259-007-0607-y
pubmed: 17909791
Goetze S, Brown TL, Lavely WC, Zhang Z, Bengel FM. Attenuation correction in myocardial perfusion SPECT/CT: effects of misregistration and value of reregistration. J Nucl Med. 2007;48(7):1090–5. https://doi.org/10.2967/jnumed.107.040535 .
doi: 10.2967/jnumed.107.040535
pubmed: 17574985
Gould KL, Pan T, Loghin C, Johnson NP, Guha A, Sdringola S. Frequent diagnostic errors in cardiac PET/CT due to misregistration of CT attenuation and emission PET images: a definitive analysis of causes, consequences, and corrections. J Nucl Med. 2007;48(7):1112–21. https://doi.org/10.2967/jnumed.107.039792 .
doi: 10.2967/jnumed.107.039792
pubmed: 17574974
Loghin C, Sdringola S, Gould KL. Common artifacts in PET myocardial perfusion images due to attenuation-emission misregistration: clinical significance, causes, and solutions. J Nucl Med. 2004;45(6):1029–39.
pubmed: 15181138
Presotto L. The long fight against motion artifacts in cardiac PET. J Nucl Cardiol. 2022;29(1):69–71. https://doi.org/10.1007/s12350-020-02232-y .
doi: 10.1007/s12350-020-02232-y
pubmed: 32557239
Armstrong IS, Hayden C, Memmott MJ, Arumugam P. A preliminary evaluation of a high temporal resolution data-driven motion correction algorithm for rubidium-82 on a SiPM PET-CT system. J Nucl Cardiol. 2022;29(1):56–68. https://doi.org/10.1007/s12350-020-02177-2 .
doi: 10.1007/s12350-020-02177-2
pubmed: 32440990
Caobelli F, Akin M, Thackeray JT, Brunkhorst T, Widder J, Berding G, et al. Diagnostic accuracy of cadmium-zinc-telluride-based myocardial perfusion SPECT: impact of attenuation correction using a co-registered external computed tomography. Eur Heart J Cardiovasc Imaging. 2016;17(9):1036–43. https://doi.org/10.1093/ehjci/jev312 .
doi: 10.1093/ehjci/jev312
pubmed: 26628617
Chopra S, Singh SS, Sood A, Parmar M, Parihar AS, Vadi SK, et al. Comparison of positional artifacts in myocardial perfusion imaging in supine and semi-reclining position using dedicated D-SPECT cardiac camera: validation using CT based attenuation correction. J Nucl Cardiol. 2023. https://doi.org/10.1007/s12350-023-03210-w .
doi: 10.1007/s12350-023-03210-w
pubmed: 36849635
Hamill JJ, Brunken RC, Bybel B, DiFilippo FP, Faul DD. A knowledge-based method for reducing attenuation artefacts caused by cardiac appliances in myocardial PET/CT. Phys Med Biol. 2006;51(11):2901–18. https://doi.org/10.1088/0031-9155/51/11/015 .
doi: 10.1088/0031-9155/51/11/015
pubmed: 16723774
Ghafarian P, Aghamiri SM, Ay MR, Rahmim A, Schindler TH, Ratib O, et al. Is metal artefact reduction mandatory in cardiac PET/CT imaging in the presence of pacemaker and implantable cardioverter defibrillator leads. Eur J Nucl Med Mol Imaging. 2011;38(2):252–62. https://doi.org/10.1007/s00259-010-1635-6 .
doi: 10.1007/s00259-010-1635-6
pubmed: 20959974
Erba PA, Lancellotti P, Vilacosta I, Gaemperli O, Rouzet F, Hacker M, et al. Recommendations on nuclear and multimodality imaging in IE and CIED infections. Eur J Nucl Med Mol Imaging. 2018;45(10):1795–815. https://doi.org/10.1007/s00259-018-4025-0 .
doi: 10.1007/s00259-018-4025-0
pubmed: 29799067
Conti D, Baruffaldi F, Erani P, Festa A, Durante S, Santoro M. Dual-energy computed tomography applications to reduce metal artifacts in hip prostheses: a phantom study. Diagnostics (Basel). 2022;13(1):50. https://doi.org/10.3390/diagnostics13010050 .
doi: 10.3390/diagnostics13010050
pubmed: 36611342
Johansen A, Grupe P, Veje A, Braad PE, Høilund-Carlsen PF. Scatter and attenuation correction changes interpretation of gated myocardial perfusion imaging. Eur J Nucl Med Mol Imaging. 2004;31(8):1152–9. https://doi.org/10.1007/s00259-004-1481-5 .
doi: 10.1007/s00259-004-1481-5
pubmed: 15118845
Sharma P, Patel CD, Karunanithi S, Maharjan S, Malhotra A. Comparative accuracy of CT attenuation-corrected and non-attenuation-corrected SPECT myocardial perfusion imaging. Clin Nucl Med. 2012;37(4):332–8. https://doi.org/10.1097/RLU.0b013e31823ea16b .
doi: 10.1097/RLU.0b013e31823ea16b
pubmed: 22391700
Greenland P, Blaha MJ, Budoff MJ, Erbel R, Watson KE. Coronary calcium score and cardiovascular risk. J Am Coll Cardiol. 2018;72(4):434–47. https://doi.org/10.1016/j.jacc.2018.05.027 .
doi: 10.1016/j.jacc.2018.05.027
pubmed: 30025580
pmcid: 6056023
Shaw LJ, Narula J. Risk assessment and predictive value of coronary artery disease testing. J Nucl Med. 2009;50(8):1296–306. https://doi.org/10.2967/jnumed.108.059592 .
doi: 10.2967/jnumed.108.059592
pubmed: 19652216
Clerc OF, Frey SM, Honegger U, Amrein MLF, Caobelli F, Haaf P, et al. Coronary artery calcium score and pre-test probabilities as gatekeepers to predict and rule out perfusion defects in positron emission tomography. J Nucl Cardiol. 2023. https://doi.org/10.1007/s12350-023-03322-3 .
doi: 10.1007/s12350-023-03322-3
pubmed: 37415007
pmcid: 10682222
Allio IR, Caobelli F, Popescu CE, Haaf P, Alberts I, Frey SM, et al. Low-dose coronary artery calcium scoring compared to the standard protocol. J Nucl Cardiol. 2023;30(3):1191–8. https://doi.org/10.1007/s12350-022-03120-3 .
doi: 10.1007/s12350-022-03120-3
pubmed: 36289163
Juarez-Orozco LE, Martinez-Manzanera O, van der Zant FM, Knol RJJ, Knuuti J. Deep learning in quantitative PET myocardial perfusion imaging: a study on cardiovascular event prediction. JACC Cardiovasc Imaging. 2020;13(1 Pt 1):180–2. https://doi.org/10.1016/j.jcmg.2019.08.009 .
doi: 10.1016/j.jcmg.2019.08.009
pubmed: 31607660
Mitchell JD, Fergestrom N, Gage BF, Paisley R, Moon P, Novak E, et al. Impact of statins on cardiovascular outcomes following coronary artery calcium scoring. J Am Coll Cardiol. 2018;72(25):3233–42. https://doi.org/10.1016/j.jacc.2018.09.051 .
doi: 10.1016/j.jacc.2018.09.051
pubmed: 30409567
pmcid: 6309473
Miller RJH, Han D, Singh A, Pieszko K, Slomka PJ, Gransar H, et al. Relationship between ischaemia, coronary artery calcium scores, and major adverse cardiovascular events. Eur Heart J Cardiovasc Imaging. 2022;23(11):1423–33. https://doi.org/10.1093/ehjci/jeac082 .
doi: 10.1093/ehjci/jeac082
pubmed: 35608211
Aljizeeri A, Ahmed AI, Alfaris MA, Ahmed D, Farea J, Elneama A, et al. Myocardial flow reserve and coronary calcification in prognosis of patients with suspected coronary artery disease. JACC Cardiovasc Imaging. 2021;14(12):2443–52. https://doi.org/10.1016/j.jcmg.2021.01.024 .
doi: 10.1016/j.jcmg.2021.01.024
pubmed: 33744156
Moser PT, Schernthaner R, Loewe C, Strassl A, Denzinger F, Faby S, et al. Evaluation of perivascular fat attenuation with coronary CT angiography in cardiac transplantation patients: an imaging biomarker candidate for prediction of cardiac mortality and re-transplantation. Eur Radiol. 2023;33(9):6299–307. https://doi.org/10.1007/s00330-023-09614-z .
doi: 10.1007/s00330-023-09614-z
pubmed: 37072507
pmcid: 10415448
Berman DS, Wong ND, Gransar H, Miranda-Peats R, Dahlbeck J, Hayes SW, et al. Relationship between stress-induced myocardial ischemia and atherosclerosis measured by coronary calcium tomography. J Am Coll Cardiol. 2004;44(4):923–30. https://doi.org/10.1016/j.jacc.2004.06.042 .
doi: 10.1016/j.jacc.2004.06.042
pubmed: 15312881
Anand DV, Lim E, Raval U, Lipkin D, Lahiri A. Prevalence of silent myocardial ischemia in asymptomatic individuals with subclinical atherosclerosis detected by electron beam tomography. J Nucl Cardiol. 2004;11(4):450–7. https://doi.org/10.1016/j.nuclcard.2004.06.125 .
doi: 10.1016/j.nuclcard.2004.06.125
pubmed: 15295414
Mc Ardle BA, Dowsley TF, deKemp RA, Wells GA, Beanlands RS. Does rubidium-82 PET have superior accuracy to SPECT perfusion imaging for the diagnosis of obstructive coronary disease?: A systematic review and meta-analysis. J Am Coll Cardiol. 2012;60(18):1828–37. https://doi.org/10.1016/j.jacc.2012.07.038 .
doi: 10.1016/j.jacc.2012.07.038
pubmed: 23040573
Jaarsma C, Leiner T, Bekkers SC, Crijns HJ, Wildberger JE, Nagel E, et al. Diagnostic performance of noninvasive myocardial perfusion imaging using single-photon emission computed tomography, cardiac magnetic resonance, and positron emission tomography imaging for the detection of obstructive coronary artery disease: a meta-analysis. J Am Coll Cardiol. 2012;59(19):1719–28. https://doi.org/10.1016/j.jacc.2011.12.040 .
doi: 10.1016/j.jacc.2011.12.040
pubmed: 22554604
Cury RC, Leipsic J, Abbara S, Achenbach S, Berman D, Bittencourt M, et al. CAD-RADS™ 2.0 - 2022 Coronary Artery Disease - Reporting and Data System.: An expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Cardiology (ACC), the American College of Radiology (ACR) and the North America Society of Cardiovascular Imaging (NASCI). J Am Coll Radiol. 2022;19(11):1185–212. https://doi.org/10.1016/j.jacr.2022.09.012 .
doi: 10.1016/j.jacr.2022.09.012
pubmed: 36436841
Maaniitty T, Jaakkola S, Saraste A, Knuuti J. Hybrid coronary computed tomography angiography and positron emission tomography myocardial perfusion imaging in evaluation of recurrent symptoms after coronary artery bypass grafting. Eur Heart J Cardiovasc Imaging. 2019;20(11):1298–304. https://doi.org/10.1093/ehjci/jey160 .
doi: 10.1093/ehjci/jey160
pubmed: 30388202
Jones DA, Beirne AM, Kelham M, Rathod KS, Andiapen M, Wynne L, et al. Computed tomography cardiac angiography before invasive coronary angiography in patients with previous bypass surgery: the BYPASS-CTCA trial. Circulation. 2023;148(18):1371–80. https://doi.org/10.1161/CIRCULATIONAHA.123.064465 .
doi: 10.1161/CIRCULATIONAHA.123.064465
pubmed: 37772419
pmcid: 11139242
Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the cardiac imaging committee of the council on clinical cardiology of the American heart association. Circulation. 2002;105(4):539–42. https://doi.org/10.1161/hc0402.102975 .
doi: 10.1161/hc0402.102975
pubmed: 11815441
Javadi MS, Lautamäki R, Merrill J, Voicu C, Epley W, McBride G, et al. Definition of vascular territories on myocardial perfusion images by integration with true coronary anatomy: a hybrid PET/CT analysis. J Nucl Med. 2010;51(2):198–203. https://doi.org/10.2967/jnumed.109.067488 .
doi: 10.2967/jnumed.109.067488
pubmed: 20080895
Bom MJ, Schumacher SP, Driessen RS, Raijmakers PG, Everaars H, van Diemen PA, et al. Impact of individualized segmentation on diagnostic performance of quantitative positron emission tomography for haemodynamically significant coronary artery disease. Eur Heart J Cardiovasc Imaging. 2019;20(5):525–32. https://doi.org/10.1093/ehjci/jey201 .
doi: 10.1093/ehjci/jey201
pubmed: 30590493
Caobelli F. Left ventricular segmentation in myocardial perfusion positron emission tomography: tailor-made or prêt-à-porter. Eur Heart J Cardiovasc Imaging. 2019;20(5):502–3. https://doi.org/10.1093/ehjci/jey216 .
doi: 10.1093/ehjci/jey216
pubmed: 30608576
AlBadri A, Piccinelli M, Cho SG, Lee JM, Jaber W, De Cecco CN, et al. Rationale and design of the quantification of myocardial blood flow using dynamic PET/CTA-fused imagery (DEMYSTIFY) to determine physiological significance of specific coronary lesions. J Nucl Cardiol. 2020;27(3):1030–9. https://doi.org/10.1007/s12350-020-02052-0 .
doi: 10.1007/s12350-020-02052-0
pubmed: 32026327
pmcid: 7332386
Namdar M, Hany TF, Koepfli P, Siegrist PT, Burger C, Wyss CA, et al. Integrated PET/CT for the assessment of coronary artery disease: a feasibility study. J Nucl Med. 2005;46(6):930–5.
pubmed: 15937302
Danad I, Raijmakers PG, Knaapen P. Diagnosing coronary artery disease with hybrid PET/CT: it takes two to tango. J Nucl Cardiol. 2013;20(5):874–90. https://doi.org/10.1007/s12350-013-9753-8 .
doi: 10.1007/s12350-013-9753-8
pubmed: 23842709
Groves PH, Pomfrett C, Marlow M. Review of the role of NICE in promoting the adoption of innovative cardiac technologies. Heart. 2018;104(22):1817–22. https://doi.org/10.1136/heartjnl-2018-313256 .
doi: 10.1136/heartjnl-2018-313256
pubmed: 29773657
Thomassen A, Petersen H, Diederichsen AC, Mickley H, Jensen LO, Johansen A, et al. Hybrid CT angiography and quantitative 15O-water PET for assessment of coronary artery disease: comparison with quantitative coronary angiography. Eur J Nucl Med Mol Imaging. 2013;40(12):1894–904. https://doi.org/10.1007/s00259-013-2519-3 .
doi: 10.1007/s00259-013-2519-3
pubmed: 23982453
Rizvi A, Han D, Danad I, Ó Hartaigh B, Lee JH, Gransar H, et al. Diagnostic performance of hybrid cardiac imaging methods for assessment of obstructive coronary artery disease compared with stand-alone coronary computed tomography angiography: a meta-analysis. JACC Cardiovasc Imaging. 2018;11(4):589–99. https://doi.org/10.1016/j.jcmg.2017.05.020 .
Danad I, Raijmakers PG, Driessen RS, Leipsic J, Raju R, Naoum C, et al. Comparison of coronary CT angiography, SPECT, PET, and hybrid imaging for diagnosis of ischemic heart disease determined by fractional flow reserve. JAMA Cardiol. 2017;2(10):1100–7. https://doi.org/10.1001/jamacardio.2017.2471 .
doi: 10.1001/jamacardio.2017.2471
pubmed: 28813561
pmcid: 5710451
Westra J, Rasmussen LD, Eftekhari A, Winther S, Karim SR, Johansen JK, et al. Coronary artery stenosis evaluation by angiography-derived FFR: validation by positron emission tomography and invasive thermodilution. JACC Cardiovasc Imaging. 2023S1936–878X(23)00105. https://doi.org/10.1016/j.jcmg.2023.02.008 .
Driessen RS, Bom MJ, van Diemen PA, Schumacher SP, Leonora RM, Everaars H, et al. Incremental prognostic value of hybrid [15O]H2O positron emission tomography-computed tomography: combining myocardial blood flow, coronary stenosis severity, and high-risk plaque morphology. Eur Heart J Cardiovasc Imaging. 2020;21(10):1105–13. https://doi.org/10.1093/ehjci/jeaa192 .
doi: 10.1093/ehjci/jeaa192
pubmed: 32959061
pmcid: 7971168
Sciagrà R, Lubberink M, Hyafil F, Saraste A, Slart RHJA, Agostini D, et al. EANM procedural guidelines for PET/CT quantitative myocardial perfusion imaging. Eur J Nucl Med Mol Imaging. 2021;48(4):1040–69. https://doi.org/10.1007/s00259-020-05046-9 .
doi: 10.1007/s00259-020-05046-9
pubmed: 33135093
Carsuzaa T, Thibault F, Bailly M. Gated tomographic radionuclide angiography using 3D-Ring CZT StarGuide SPECT/CT head-to-head comparison with a cardiac-dedicated CZT camera: first clinical use and validation. Clin Nucl Med. 2022;47(7):e515–7. https://doi.org/10.1097/RLU.0000000000004153 .
doi: 10.1097/RLU.0000000000004153
pubmed: 35353756
Ben Bouallègue F, Maïmoun L, Kucharczak F, Le Fur P, Vauchot F, Hay B, et al. Left ventricle function assessment using gated first-pass
doi: 10.1007/s12350-019-01731-x
pubmed: 31044403
Zaidi H, Hasegawa B. Determination of the attenuation map in emission tomography. J Nucl Med. 2003;44(2):291–315.
pubmed: 12571222
Slomka PJ, Diaz-Zamudio M, Dey D, Motwani M, Brodov Y, Choi D, et al. Automatic registration of misaligned CT attenuation correction maps in Rb-82 PET/CT improves detection of angiographically significant coronary artery disease. J Nucl Cardiol. 2015;22(6):1285–95. https://doi.org/10.1007/s12350-014-0060-9 .
doi: 10.1007/s12350-014-0060-9
pubmed: 25698471
Kennedy JA, Israel O, Frenkel A. Directions and magnitudes of misregistration of CT attenuation-corrected myocardial perfusion studies: incidence, impact on image quality, and guidance for reregistration. J Nucl Med. 2009;50(9):1471–8. https://doi.org/10.2967/jnumed.109.062141 .
doi: 10.2967/jnumed.109.062141
pubmed: 19690038
O’Connor MK, Kemp BJ. Single-photon emission computed tomography/computed tomography: basic instrumentation and innovations. Semin Nucl Med. 2006;36(4):258–66. https://doi.org/10.1053/j.semnuclmed.2006.05.005 .
doi: 10.1053/j.semnuclmed.2006.05.005
pubmed: 16950143
Delgado V, Ajmone Marsan N, de Waha S, Bonaros N, Brida M, Burri H, et al. 2023 ESC Guidelines for the management of endocarditis. Eur Heart J. 2023ehad193. https://doi.org/10.1093/eurheartj/ehad193 .
Bourque JM, Birgersdotter-Green U, Bravo PE, Budde RPJ, Chen W, Chu VH, et al. 18F-FDG PET/CT and radiolabeled leukocyte SPECT/CT imaging for the evaluation of cardiovascular infection in the multimodality context. JACC: Cardiovasc Imaging. 2024. https://doi.org/10.1016/j.jcmg.2024.01.004 .
Bourque JM, Birgersdotter-Green U, Bravo PE, Budde RPJ, Chen W, Chu VH, et al.
doi: 10.1016/j.nuclcard.2023.101786
pubmed: 38472038
Blomström-Lundqvist C, Traykov V, Erba PA, Burri H, Nielsen JC, Bongiorni MG, et al. European heart rhythm association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Europace. 2020;22(4):515–49. https://doi.org/10.1093/europace/euz246 .
doi: 10.1093/europace/euz246
pubmed: 31702000
Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, et al. 2015 ESC Guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the european society of cardiology (ESC). Endorsed by: European association for cardio-thoracic surgery (EACTS), the European association of nuclear medicine (EANM). Eur Heart J. 2015;36(44):3075–128. https://doi.org/10.1093/eurheartj/ehv319 .
doi: 10.1093/eurheartj/ehv319
pubmed: 26320109
Pizzi MN, Roque A, Cuéllar-Calabria H, Fernández-Hidalgo N, Ferreira-González I, González-Alujas MT, et al.
doi: 10.1016/j.jcmg.2016.05.013
pubmed: 27639767
Pizzi MN, Roque A, Fernández-Hidalgo N, Cuéllar-Calabria H, Ferreira-González I, Gonzàlez-Alujas MT, et al. Improving the diagnosis of infective endocarditis in prosthetic valves and intracardiac devices With 18F-Fluordeoxyglucose positron emission tomography/computed tomography angiography: initial results at an infective endocarditis referral center. Circulation. 2015;132(12):1113–26. https://doi.org/10.1161/CIRCULATIONAHA.115.015316 .
doi: 10.1161/CIRCULATIONAHA.115.015316
pubmed: 26276890
Salaun E, Sportouch L, Barral PA, Hubert S, Lavoute C, Casalta AC, et al. Diagnosis of infective endocarditis after TAVR: value of a multimodality imaging approach. JACC Cardiovasc Imaging. 2018;11(1):143–6. https://doi.org/10.1016/j.jcmg.2017.05.016 .
doi: 10.1016/j.jcmg.2017.05.016
pubmed: 28823740
Wahadat AR, Tanis W, Swart LE, Scholtens A, Krestin GP, van Mieghem NMDA, et al. Added value of
doi: 10.1007/s12350-019-01963-x
pubmed: 31792918
Olivella A, Pizzi MN, Dos-Subirà L, Aguadé-Bruix S, Fernández-Hidalgo N, Cuéllar-Calabria H, et al. Right-sided endocarditis on Contegra tube in a complex cianotic congenital heart disease. J Nucl Cardiol. 2020;27(4):1402–4. https://doi.org/10.1007/s12350-019-01708-w .
doi: 10.1007/s12350-019-01708-w
pubmed: 30972721
Signore A, Jamar F, Israel O, Buscombe J, Martin-Comin J, Lazzeri E. Clinical indications, image acquisition and data interpretation for white blood cells and anti-granulocyte monoclonal antibody scintigraphy: an EANM procedural guideline. Eur J Nucl Med Mol Imaging. 2018;45(10):1816–31. https://doi.org/10.1007/s00259-018-4052-x .
doi: 10.1007/s00259-018-4052-x
pubmed: 29850929
pmcid: 6097781
Rouzet F, Chequer R, Benali K, Lepage L, Ghodbane W, Duval X, et al. Respective performance of 18F-FDG PET and radiolabeled leukocyte scintigraphy for the diagnosis of prosthetic valve endocarditis. J Nucl Med. 2014;55(12):1980–5. https://doi.org/10.2967/jnumed.114.141895 .
doi: 10.2967/jnumed.114.141895
pubmed: 25453046
Caobelli F, Wollenweber T, Bavendiek U, Kühn C, Schütze C, Geworski L, et al. Simultaneous dual-isotope solid-state detector SPECT for improved tracking of white blood cells in suspected endocarditis. Eur Heart J. 2017;38(6):436–43. https://doi.org/10.1093/eurheartj/ehw231 .
doi: 10.1093/eurheartj/ehw231
pubmed: 27469371
Genovesi D, Bauckneht M, Altini C, Popescu CE, Ferro P, Monaco L, et al. The role of positron emission tomography in the assessment of cardiac sarcoidosis. Br J Radiol. 2019;92(1100):20190247. https://doi.org/10.1259/bjr.20190247 .
doi: 10.1259/bjr.20190247
pubmed: 31166768
pmcid: 6724628
Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum. 2013;65(1):1–11. https://doi.org/10.1002/art.37715 .
doi: 10.1002/art.37715
pubmed: 23045170
Pugh D, Karabayas M, Basu N, Cid MC, Goel R, Goodyear CS, et al. Large-vessel vasculitis. Nat Rev Dis Primers. 2022;7(1):93. https://doi.org/10.1038/s41572-021-00327-5 .
doi: 10.1038/s41572-021-00327-5
pubmed: 34992251
pmcid: 9115766
Yamada I, Nakagawa T, Himeno Y, Numano F, Shibuya H. Takayasu arteritis: evaluation of the thoracic aorta with CT angiography. Radiology. 1998;209(1):103–9. https://doi.org/10.1148/radiology.209.1.9769819 .
doi: 10.1148/radiology.209.1.9769819
pubmed: 9769819
Hur JH, Chun EJ, Kwag HJ, Yoo JY, Kim HY, Kim JJ, et al. CT features of vasculitides based on the 2012 international Chapel Hill consensus conference revised classification. Korean J Radiol. 2017;18(5):786–98. https://doi.org/10.3348/kjr.2017.18.5.786 .
doi: 10.3348/kjr.2017.18.5.786
pubmed: 28860896
pmcid: 5552462
García-Martínez A, Arguis P, Prieto-González S, Espígol-Frigolé G, Alba MA, Butjosa M, et al. Prospective long term follow-up of a cohort of patients with giant cell arteritis screened for aortic structural damage (aneurysm or dilatation). Ann Rheum Dis. 2014;73(10):1826–32. https://doi.org/10.1136/annrheumdis-2013-203322 .
doi: 10.1136/annrheumdis-2013-203322
pubmed: 23873881
Koch V, Abt J, Gruenewald LD, Eichler K, D’Angelo T, Martin SS, et al. Systematic evaluation of imaging techniques and baseline characteristics in patients with suspected vasculitis. Eur J Radiol Open. 2022;9:100445. https://doi.org/10.1016/j.ejro.2022.100445 .
doi: 10.1016/j.ejro.2022.100445
pubmed: 36262692
pmcid: 9574707
Jamar F, Buscombe J, Chiti A, Christian PE, Delbeke D, Donohoe KJ, et al. EANM/SNMMI guideline for 18F-FDG use in inflammation and infection. J Nucl Med. 2013;54(4):647–58. https://doi.org/10.2967/jnumed.112.112524 .
doi: 10.2967/jnumed.112.112524
pubmed: 23359660
Slart RHJA, Writing G, Reviewer G, Members OEANMC, Members OEANMII, Members of Committees SNMMIC, et al. FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC. Eur J Nucl Med Mol Imaging. 2018;45(7):1250–69. https://doi.org/10.1007/s00259-018-3973-8 .
Lariviere D, Benali K, Coustet B, Pasi N, Hyafil F, Klein I, et al. Positron emission tomography and computed tomography angiography for the diagnosis of giant cell arteritis: A real-life prospective study. Medicine (Baltimore). 2016;95(30):e4146. https://doi.org/10.1097/MD.0000000000004146 .
doi: 10.1097/MD.0000000000004146
pubmed: 27472684
Lensen KD, Comans EF, Voskuyl AE, van der Laken CJ, Brouwer E, Zwijnenburg AT, et al. Large-vessel vasculitis: interobserver agreement and diagnostic accuracy of 18F-FDG-PET/CT. Biomed Res Int. 2015;2015:914692. https://doi.org/10.1155/2015/914692 .
doi: 10.1155/2015/914692
pubmed: 25695092
pmcid: 4324480
Bucerius J, Hyafil F, Verberne HJ, Slart RH, Lindner O, Sciagra R, et al. Position paper of the cardiovascular committee of the European association of nuclear medicine (EANM) on PET imaging of atherosclerosis. Eur J Nucl Med Mol Imaging. 2016;43(4):780–92. https://doi.org/10.1007/s00259-015-3259-3 .
doi: 10.1007/s00259-015-3259-3
pubmed: 26678270
Nielsen BD, Gormsen LC, Hansen IT, Keller KK, Therkildsen P, Hauge EM. Three days of high-dose glucocorticoid treatment attenuates large-vessel 18F-FDG uptake in large-vessel giant cell arteritis but with a limited impact on diagnostic accuracy. Eur J Nucl Med Mol Imaging. 2018;45(7):1119–28. https://doi.org/10.1007/s00259-018-4021-4 .
doi: 10.1007/s00259-018-4021-4
pubmed: 29671039
Drent M, Crouser ED, Grunewald J. Challenges of sarcoidosis and its management. N Engl J Med. 2021;385(11):1018–32. https://doi.org/10.1056/NEJMra2101555 .
doi: 10.1056/NEJMra2101555
pubmed: 34496176
Statement on sarcoidosis. Joint statement of the American thoracic society (ATS), the European respiratory society (ERS) and the World association of sarcoidosis and other granulomatous disorders (WASOG) adopted by the ATS board of directors and by the ers executive committee, february 1999. Am J Respir Crit Care Med. 1999;160(2):736–55. https://doi.org/10.1164/ajrccm.160.2.ats4-99 .
doi: 10.1164/ajrccm.160.2.ats4-99
Régis C, Benali K, Rouzet F. FDG PET/CT imaging of sarcoidosis. Semin Nucl Med. 2023;53(2):258–72. https://doi.org/10.1053/j.semnuclmed.2022.08.004 .
doi: 10.1053/j.semnuclmed.2022.08.004
pubmed: 36870707
Lobert P, Brown RK, Dvorak RA, Corbett JR, Kazerooni EA, Wong KK. Spectrum of physiological and pathological cardiac and pericardial uptake of FDG in oncology PET-CT. Clin Radiol. 2013;68(1):e59-71. https://doi.org/10.1016/j.crad.2012.09.007 .
doi: 10.1016/j.crad.2012.09.007
pubmed: 23177651
Ozutemiz C, Koksel Y, Froelich JW, Rubin N, Bhargava M, Roukuz H, et al. Comparison of the effect of three different dietary modifications on myocardial suppression in
doi: 10.2967/jnumed.121.261981
pubmed: 33771904
pmcid: 8612186
Lucinian YA, Martineau P, Poenaru R, Tremblay-Gravel M, Cadrin-Tourigny J, Harel F, et al. FDG-PET/CT and rest myocardial perfusion imaging to predict high-degree atrioventricular block recovery in cardiac sarcoidosis. J Nucl Cardiol. 2023;30(6):2490–500. https://doi.org/10.1007/s12350-023-03306-3 .
doi: 10.1007/s12350-023-03306-3
pubmed: 37258950
Slart RHJA, Glaudemans AWJM, Gheysens O, Lubberink M, Kero T, Dweck MR, et al. Procedural recommendations of cardiac PET/CT imaging: standardization in inflammatory-, infective-, infiltrative-, and innervation (4Is)-related cardiovascular diseases: a joint collaboration of the EACVI and the EANM. Eur J Nucl Med Mol Imaging. 2021;48(4):1016–39. https://doi.org/10.1007/s00259-020-05066-5 .
doi: 10.1007/s00259-020-05066-5
pubmed: 33106926
Perugini E, Guidalotti PL, Salvi F, Cooke RM, Pettinato C, Riva L, et al. Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy. J Am Coll Cardiol. 2005;46(6):1076–84. https://doi.org/10.1016/j.jacc.2005.05.073 .
doi: 10.1016/j.jacc.2005.05.073
pubmed: 16168294
Garcia-Pavia P, Rapezzi C, Adler Y, Arad M, Basso C, Brucato A, et al. Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC working group on myocardial and pericardial diseases. Eur Heart J. 2021;42(16):1554–68. https://doi.org/10.1093/eurheartj/ehab072 .
doi: 10.1093/eurheartj/ehab072
pubmed: 33825853
pmcid: 8060056
Hanna M, Ruberg FL, Maurer MS, Dispenzieri A, Dorbala S, Falk RH, et al. Cardiac scintigraphy with technetium-99m-labeled bone-seeking tracers for suspected amyloidosis: JACC review topic of the week. J Am Coll Cardiol. 2020;75(22):2851–62. https://doi.org/10.1016/j.jacc.2020.04.022 .
doi: 10.1016/j.jacc.2020.04.022
pubmed: 32498813
Caobelli F, Braun M, Haaf P, Wild D, Zellweger MJ. Quantitative
doi: 10.1007/s12350-019-01893-8
pubmed: 31538322
Prakken NHJ, Besson FL, Borra RJH, Büther F, Buechel RR, Catana C, et al. PET/MRI in practice: a clinical centre survey endorsed by the European Association of Nuclear Medicine (EANM) and the EANM Forschungs GmbH (EARL). Eur J Nucl Med Mol Imaging. 2023;50(10):2927–34. https://doi.org/10.1007/s00259-023-06308-y .
doi: 10.1007/s00259-023-06308-y
pubmed: 37378857
Trivieri MG, Dweck MR, Abgral R, Robson PM, Karakatsanis NA, Lala A, et al.
doi: 10.1016/j.jacc.2016.09.953
pubmed: 27978955
pmcid: 5438164
Dweck MR, Abgral R, Trivieri MG, Robson PM, Karakatsanis N, Mani V, et al. Hybrid magnetic resonance imaging and positron emission tomography with fluorodeoxyglucose to diagnose active cardiac sarcoidosis. JACC Cardiovasc Imaging. 2018;11(1):94–107. https://doi.org/10.1016/j.jcmg.2017.02.021 .
doi: 10.1016/j.jcmg.2017.02.021
pubmed: 28624396
Ćorović A, Wall C, Nus M, Gopalan D, Huang Y, Imaz M, et al. Somatostatin receptor PET/MR imaging of inflammation in patients with large vessel vasculitis and atherosclerosis. J Am Coll Cardiol. 2023;81(4):336–54. https://doi.org/10.1016/j.jacc.2022.10.034 .
doi: 10.1016/j.jacc.2022.10.034
pubmed: 36697134
pmcid: 9883634
Abgral R, Dweck MR, Trivieri MG, Robson PM, Karakatsanis N, Mani V, et al. Clinical utility of combined FDG-PET/MR to assess myocardial disease. JACC Cardiovasc Imaging. 2017;10(5):594–7. https://doi.org/10.1016/j.jcmg.2016.02.029 .
doi: 10.1016/j.jcmg.2016.02.029
pubmed: 27372018
Robson PM, Dweck MR, Trivieri MG, Abgral R, Karakatsanis NA, Contreras J, et al. Coronary Artery PET/MR Imaging: Feasibility, Limitations, and Solutions. JACC Cardiovasc Imaging. 2017;10(10 Pt A):1103–12. https://doi.org/10.1016/j.jcmg.2016.09.029 .
von Felten E, Benetos G, Patriki D, Benz DC, Rampidis GP, Giannopoulos AA, et al. Myocardial creep-induced misalignment artifacts in PET/MR myocardial perfusion imaging. Eur J Nucl Med Mol Imaging. 2021;48(2):406–13. https://doi.org/10.1007/s00259-020-04956-y .
doi: 10.1007/s00259-020-04956-y
Zhang Z, Chen X, Wan Q, Wang H, Qi N, You Z, et al. A two-stage cardiac PET and late gadolinium enhancement MRI co-registration method for improved assessment of non-ischemic cardiomyopathies using integrated PET/MR. Eur J Nucl Med Mol Imaging. 2022;49(7):2199–208. https://doi.org/10.1007/s00259-022-05681-4 .
doi: 10.1007/s00259-022-05681-4
pubmed: 35031812
Bogdanovic B, Gafita A, Schachoff S, Eiber M, Cabello J, Weber WA, et al. Almost 10 years of PET/MR attenuation correction: the effect on lesion quantification with PSMA: clinical evaluation on 200 prostate cancer patients. Eur J Nucl Med Mol Imaging. 2021;48(2):543–53. https://doi.org/10.1007/s00259-020-04957-x .
doi: 10.1007/s00259-020-04957-x
pubmed: 32725538
Ghosh N, Rimoldi OE, Beanlands RS, Camici PG. Assessment of myocardial ischaemia and viability: role of positron emission tomography. Eur Heart J. 2010;31(24):2984–95. https://doi.org/10.1093/eurheartj/ehq361 .
doi: 10.1093/eurheartj/ehq361
pubmed: 20965888
Beanlands RS, Hendry PJ, Masters RG, deKemp RA, Woodend K, Ruddy TD. Delay in revascularization is associated with increased mortality rate in patients with severe left ventricular dysfunction and viable myocardium on fluorine 18-fluorodeoxyglucose positron emission tomography imaging. Circulation. 1998;98(19 Suppl):II51–6.
Nensa F, Poeppel TD, Beiderwellen K, Schelhorn J, Mahabadi AA, Erbel R, et al. Hybrid PET/MR imaging of the heart: feasibility and initial results. Radiology. 2013;268(2):366–73. https://doi.org/10.1148/radiol.13130231 .
doi: 10.1148/radiol.13130231
pubmed: 23651530
Rischpler C, Langwieser N, Souvatzoglou M, Batrice A, van Marwick S, Snajberk J, et al. PET/MRI early after myocardial infarction: evaluation of viability with late gadolinium enhancement transmurality vs. 18F-FDG uptake. Eur Heart J Cardiovasc Imaging. 2015;16(6):661–9. https://doi.org/10.1093/ehjci/jeu317 .
Vitadello T, Kunze KP, Nekolla SG, Langwieser N, Bradaric C, Weis F, et al. Hybrid PET/MR imaging for the prediction of left ventricular recovery after percutaneous revascularisation of coronary chronic total occlusions. Eur J Nucl Med Mol Imaging. 2020;47(13):3074–83. https://doi.org/10.1007/s00259-020-04877-w .
doi: 10.1007/s00259-020-04877-w
pubmed: 32472438
pmcid: 7680332
Peretto G, Busnardo E, Ferro P, Palmisano A, Vignale D, Esposito A, et al. Clinical applications of FDG-PET scan in arrhythmic myocarditis. JACC Cardiovasc Imaging. 2022;15(10):1771–80. https://doi.org/10.1016/j.jcmg.2022.02.029 .
doi: 10.1016/j.jcmg.2022.02.029
pubmed: 36202457
Caobelli F, Cabrero JB, Galea N, Haaf P, Loewe C, Luetkens JA, et al. Cardiovascular magnetic resonance (CMR) and positron emission tomography (PET) imaging in the diagnosis and follow-up of patients with acute myocarditis and chronic inflammatory cardiomyopathy : A review paper with practical recommendations on behalf of the European Society of Cardiovascular Radiology (ESCR). Int J Cardiovasc Imaging. 2023;39(11):2221–35. https://doi.org/10.1007/s10554-023-02927-6 .
doi: 10.1007/s10554-023-02927-6
pubmed: 37682416
pmcid: 10674005
Nensa F, Poeppel TD, Krings P, Schlosser T. Multiparametric assessment of myocarditis using simultaneous positron emission tomography/magnetic resonance imaging. Eur Heart J. 2014;35(32):2173. https://doi.org/10.1093/eurheartj/ehu086 .
doi: 10.1093/eurheartj/ehu086
pubmed: 24578391
von Olshausen G, Hyafil F, Langwieser N, Laugwitz KL, Schwaiger M, Ibrahim T. Detection of acute inflammatory myocarditis in Epstein Barr virus infection using hybrid 18F-fluoro-deoxyglucose-positron emission tomography/magnetic resonance imaging. Circulation. 2014;130(11):925–6. https://doi.org/10.1161/CIRCULATIONAHA.114.011000 .
doi: 10.1161/CIRCULATIONAHA.114.011000
Piriou N, Sassier J, Pallardy A, Serfaty JM, Trochu JN. Utility of cardiac FDG-PET imaging coupled to magnetic resonance for the management of an acute myocarditis with non-informative endomyocardial biopsy. Eur Heart J Cardiovasc Imaging. 2015;16(5):574. https://doi.org/10.1093/ehjci/jeu319 .
doi: 10.1093/ehjci/jeu319
pubmed: 25588796
Nensa F, Kloth J, Tezgah E, Poeppel TD, Heusch P, Goebel J, et al. Feasibility of FDG-PET in myocarditis: comparison to CMR using integrated PET/MRI. J Nucl Cardiol. 2018;25(3):785–94. https://doi.org/10.1007/s12350-016-0616-y .
doi: 10.1007/s12350-016-0616-y
pubmed: 27638745
Amano J, Nakayama J, Yoshimura Y, Ikeda U. Clinical classification of cardiovascular tumors and tumor-like lesions, and its incidences. Gen Thorac Cardiovasc Surg. 2013;61(8):435–47. https://doi.org/10.1007/s11748-013-0214-8 .
doi: 10.1007/s11748-013-0214-8
pubmed: 23460447
pmcid: 3732772
Qin C, Shao F, Hu F, Song W, Song Y, Guo J, et al.
doi: 10.1007/s00259-019-04632-w
pubmed: 31807883
Palaskas N, Thompson K, Gladish G, Agha AM, Hassan S, Iliescu C, et al. Evaluation and management of cardiac tumors. Curr Treat Options Cardiovasc Med. 2018;20(4):29. https://doi.org/10.1007/s11936-018-0625-z .
doi: 10.1007/s11936-018-0625-z
pubmed: 29556752
Hendel RC, Patel MR, Kramer CM, Poon M, Hendel RC, Carr JC, et al. ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American college of cardiology foundation quality strategic directions committee appropriateness criteria working group, American college of radiology, Society of cardiovascular computed tomography, Society for cardiovascular magnetic resonance, American society of nuclear cardiology, North American society for cardiac imaging, Society for cardiovascular angiography and interventions, and Society of interventional radiology. J Am Coll Cardiol. 2006;48(7):1475–97. https://doi.org/10.1016/j.jacc.2006.07.003 .
Parwani P, Co M, Ramesh T, Akhter N, Iliescu C, Palaskas N, et al. Differentiation of cardiac masses by cardiac magnetic resonance imaging. Curr Cardiovasc Imaging Rep. 2020;13(1) https://doi.org/10.1007/s12410-019-9522-4 .
Yin H, Mao W, Tan H, Zhu N, Wan Q, Shi J, et al. Role of
doi: 10.1007/s12350-020-02510-9
pubmed: 33462788
Bernhard B, Gräni C. 18F-FDG PET/CT imaging in the workup of cardiac and pericardial masses. J Nucl Cardiol. 2022;29(6):3466–8. https://doi.org/10.1007/s12350-021-02539-4 .
doi: 10.1007/s12350-021-02539-4
pubmed: 33604789
Rahbar K, Seifarth H, Schäfers M, Stegger L, Hoffmeier A, Spieker T, et al. Differentiation of malignant and benign cardiac tumors using 18F-FDG PET/CT. J Nucl Med. 2012;53(6):856–63. https://doi.org/10.2967/jnumed.111.095364 .
doi: 10.2967/jnumed.111.095364
pubmed: 22577239
Nensa F, Tezgah E, Poeppel TD, Jensen CJ, Schelhorn J, Köhler J, et al. Integrated 18F-FDG PET/MR imaging in the assessment of cardiac masses: a pilot study. J Nucl Med. 2015;56(2):255–60. https://doi.org/10.2967/jnumed.114.147744 .
doi: 10.2967/jnumed.114.147744
pubmed: 25552667
Aghayev A, Cheezum MK, Steigner ML, Mousavi N, Padera R, Barac A, et al. Multimodality imaging to distinguish between benign and malignant cardiac masses. J Nucl Cardiol. 2022;29(4):1504–17. https://doi.org/10.1007/s12350-021-02790-9 .
doi: 10.1007/s12350-021-02790-9
pubmed: 34476778
Mikail N, Males L, Hyafil F, Benali K, Deschamps L, Brochet E, et al. Diagnosis and staging of cardiac masses: additional value of CMR with
doi: 10.1007/s00259-022-05709-9
pubmed: 35247063
Andrews JPM, Trivieri MG, Everett R, Spath N, MacNaught G, Moss AJ, et al. 18F-fluoride PET/MR in cardiac amyloid: a comparison study with aortic stenosis and age- and sex-matched controls. J Nucl Cardiol. 2022;29(2):741–9. https://doi.org/10.1007/s12350-020-02356-1 .
doi: 10.1007/s12350-020-02356-1
pubmed: 33000405
Martineau P, Finnerty V, Giraldeau G, Authier S, Harel F, Pelletier-Galarneau M. Examining the sensitivity of 18F-NaF PET for the imaging of cardiac amyloidosis. J Nucl Cardiol. 2021;28(1):209–18. https://doi.org/10.1007/s12350-019-01675-2 .
doi: 10.1007/s12350-019-01675-2
pubmed: 30834499
Abulizi M, Sifaoui I, Wuliya-Gariepy M, Kharoubi M, Israël JM, Emsen B, et al.
doi: 10.1007/s12350-019-01885-8
pubmed: 31512197
Baratto L, Park SY, Hatami N, Gulaka P, Vasanawala S, Yohannan TK, et al.
doi: 10.1186/s13550-018-0425-1
pubmed: 30043115
pmcid: 6057864
Bi X, Xu B, Liu J, Wang G, An J, Zhang X, et al. Diagnostic value of
doi: 10.3389/fcvm.2022.830572
pubmed: 35369284
pmcid: 8966842
Wisenberg G, Thiessen JD, Pavlovsky W, Butler J, Wilk B, Prato FS. Same day comparison of PET/CT and PET/MR in patients with cardiac sarcoidosis. J Nucl Cardiol. 2020;27(6):2118–29. https://doi.org/10.1007/s12350-018-01578-8 .
doi: 10.1007/s12350-018-01578-8
pubmed: 30603887
Sgard B, Brillet PY, Bouvry D, Djelbani S, Nunes H, Meune C, et al. Evaluation of FDG PET combined with cardiac MRI for the diagnosis and therapeutic monitoring of cardiac sarcoidosis. Clin Radiol. 2019;74(1):81.e9-81.e18. https://doi.org/10.1016/j.crad.2018.09.015 .
doi: 10.1016/j.crad.2018.09.015
pubmed: 30482560
Schneider S, Batrice A, Rischpler C, Eiber M, Ibrahim T, Nekolla SG. Utility of multimodal cardiac imaging with PET/MRI in cardiac sarcoidosis: implications for diagnosis, monitoring and treatment. Eur Heart J. 2014;35(5):312. https://doi.org/10.1093/eurheartj/eht335 .
doi: 10.1093/eurheartj/eht335
pubmed: 23975480
Wicks EC, Menezes LJ, Barnes A, Mohiddin SA, Sekhri N, Porter JC, et al. Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in cardiac sarcoidosis. Eur Heart J Cardiovasc Imaging. 2018;19(7):757–67. https://doi.org/10.1093/ehjci/jex340 .
doi: 10.1093/ehjci/jex340
pubmed: 29319785
Greulich S, Gatidis S, Gräni C, Blankstein R, Glatthaar A, Mezger K, et al. Hybrid cardiac magnetic resonance/fluorodeoxyglucose positron emission tomography to differentiate active from chronic cardiac sarcoidosis. JACC Cardiovasc Imaging. 2022;15(3):445–56. https://doi.org/10.1016/j.jcmg.2021.08.018 .
doi: 10.1016/j.jcmg.2021.08.018
pubmed: 34656480
Tawakol A, Fayad ZA, Mogg R, Alon A, Klimas MT, Dansky H, et al. Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multicenter fluorodeoxyglucose-positron emission tomography/computed tomography feasibility study. J Am Coll Cardiol. 2013;62(10):909–17. https://doi.org/10.1016/j.jacc.2013.04.066 .
doi: 10.1016/j.jacc.2013.04.066
pubmed: 23727083
Joshi NV, Vesey AT, Williams MC, Shah AS, Calvert PA, Craighead FH, et al. 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial. Lancet. 2014;383(9918):705–13. https://doi.org/10.1016/S0140-6736(13)61754-7 .
doi: 10.1016/S0140-6736(13)61754-7
pubmed: 24224999
Tarkin JM, Calcagno C, Dweck MR, Evans NR, Chowdhury MM, Gopalan D, et al.
doi: 10.1016/j.jacc.2019.02.052
pubmed: 31097170
pmcid: 6525109
Hyafil F, Pelisek J, Laitinen I, Schottelius M, Mohring M, Döring Y, et al. Imaging the cytokine receptor CXCR4 in atherosclerotic plaques with the radiotracer
doi: 10.2967/jnumed.116.179663
pubmed: 27789718
Li X, Yu W, Wollenweber T, Lu X, Wei Y, Beitzke D, et al. [
doi: 10.1007/s00259-019-04322-7
pubmed: 31004184
pmcid: 6584241
Hyafil F, Schindler A, Sepp D, Obenhuber T, Bayer-Karpinska A, Boeckh-Behrens T, et al. High-risk plaque features can be detected in non-stenotic carotid plaques of patients with ischaemic stroke classified as cryptogenic using combined (18)F-FDG PET/MR imaging. Eur J Nucl Med Mol Imaging. 2016;43(2):270–9. https://doi.org/10.1007/s00259-015-3201-8 .
doi: 10.1007/s00259-015-3201-8
pubmed: 26433367
Blockmans D, Coudyzer W, Vanderschueren S, Stroobants S, Loeckx D, Heye S, et al. Relationship between fluorodeoxyglucose uptake in the large vessels and late aortic diameter in giant cell arteritis. Rheumatology (Oxford). 2008;47(8):1179–84. https://doi.org/10.1093/rheumatology/ken119 .
doi: 10.1093/rheumatology/ken119
pubmed: 18515868
Cerne JW, Liu S, Umair M, Pathrose A, Moore JE, Allen BD, et al. Combined modality PET/MR for the detection of severe large vessel vasculitis. Eur J Hybrid Imaging. 2022;6(1):16. https://doi.org/10.1186/s41824-022-00136-3 .
doi: 10.1186/s41824-022-00136-3
pubmed: 35965266
pmcid: 9376186
Padoan R, Crimì F, Felicetti M, Padovano F, Lacognata C, Stramare R, et al. Fully integrated [18F]FDG PET/MR in large vessel vasculitis. Q J Nucl Med Mol Imaging. 2022;66(3):272–9. https://doi.org/10.23736/S1824-4785.19.03184-4 .
doi: 10.23736/S1824-4785.19.03184-4
pubmed: 31602964
Rischpler C, Nekolla SG, Dregely I, Schwaiger M. Hybrid PET/MR imaging of the heart: potential, initial experiences, and future prospects. J Nucl Med. 2013;54(3):402–15. https://doi.org/10.2967/jnumed.112.105353 .
doi: 10.2967/jnumed.112.105353
pubmed: 23404088